Actively Recruiting
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
Led by Fu Jen Catholic University · Updated on 2026-03-05
100
Participants Needed
1
Research Sites
81 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.
CONDITIONS
Official Title
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients requiring thoracentesis for pleural effusion drainage as determined by a physician based on clinical need.
- Signed informed consent.
You will not qualify if you...
- Patients under the age of 18.
- Patients with malignancies other than lung adenocarcinoma.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fu Jen Catholic University Hospital, Fu Jen Catholic University
New Taipei City, Taiwan, 24352
Actively Recruiting
Research Team
K
Ke-Yun Chao, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here